Kevin Windsor

Andecaliximab/GS-5745 Alone and Combined with mFOLFOX6 in Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Results from a Phase I Study

Manish A. Shah, Alexander Starodub, Sunil Sharma et al. · Clinical Cancer Research · 2018 · 90 citations · Full text

A Comparison of Efficacy of Sargramostim (Yeast-Derived RhuGM-CSF) and Filgrastim (Bacteria-Derived RhuG-CSF) in the Therapeutic Setting of Chemotherapy-Induced Myelosuppression

Roy Beveridge, John A. Miller, Arthur N. Kales et al. · Cancer Investigation · 1998 · 64 citations

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Meletios Α. Dimopoulos, Paul G. Richardson, Nizar J. Bahlis et al. · The Lancet Haematology · 2022 · 44 citations

Hematological Malignancy, Oncology, Transplantation +8

Safety and Efficacy of Andecaliximab (GS-5745) Plus Gemcitabine and Nab-Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study

Johanna C. Bendell, Sunil Sharma, Manish R. Patel et al. · The Oncologist · 2020 · 26 citations · Full text

Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphoma

Shaker R. Dakhil, Róbert Hermann, Marshall T. Schreeder et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 25 citations

Immunology, Pathology, Pharmacotherapy +16